The clinical utility of molecular imaging in COVID-19: An update Review


Authors: Elsakka, A.; Yeh, R.; Das, J.
Review Title: The clinical utility of molecular imaging in COVID-19: An update
Abstract: The novel pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first discovered in Wuhan, China in late 2019 with Coronavirus disease 2019 (COVID-19) declared a global pandemic in March 2020. Primarily involving the lungs, conventional imaging with chest radiography and CT can play a complementary role to RT-PCR in the ini-tial diagnosis, and also in follow up of select patients. As a broader understanding of the multi-systemic nature of COVID-19 has evolved, a potential role for molecular imaging has developed, that may detect functional changes in advance of standard cross-sectional imaging. In this review, we highlight the evolving role of molecular imaging such as fluo-rine-18 (18F) fluorodeoxyglucose (FDG) with PET/CT and PET/MRI in the evaluation of both pulmonary and extra-pulmonary COVID-19, ventilation and perfusion scan with SPECT/CT for thromboembolic disease, long term follow-up of COVID-19 infection, and COVID-19 vaccine-related complications.Semin Nucl Med 53:98-106 (c) 2022 Elsevier Inc. All rights reserved.
Keywords: scintigraphy; fdg-pet/ct; ct findings
Journal Title: Seminars in Nuclear Medicine
Volume: 53
Issue: 1
ISSN: 0001-2998
Publisher: Elsevier Inc.  
Date Published: 2023-01-01
Start Page: 98
End Page: 106
Language: English
ACCESSION: WOS:000892495800009
DOI: 10.1053/j.semnuclmed.2022.09.002
PROVIDER: wos
PMCID: PMC9492514
PUBMED: 36243572
Notes: Randy Yeh is the corresponding author -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Randy Yeh
    38 Yeh
  2. Jeeban Paul Das
    25 Das